Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Sweden
Finland
Denmark
Norway
Latest
Trending
Followed

Haypp Group, Audiocast, Q3'25

By Inderes11/5/2025, 3:00 PM
Haypp Group

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Gavin O'Dowd
00:01 - 05:18

Good afternoon, everybody, and welcome to the afternoon variant of our Q3 2025 conference call. Our CFO, Peter Delhi, and I, Gavin O'Dowd, will take you through our results starting on slide four. I would like to focus on four key aspects of our operational highlights, beginning first with our Nicotine Pouches Q3 volume, which shows a year-on-year growth of 21% on a like-for-like basis. It should be noted that Q3 last year had an exceptionally high traffic base in the US, which I will provide more details on in the next slide. Secondly, like-for-like sales grew 15% for the period, affected by the accelerated decline in Snus sales during the same timeframe. Thirdly, the gross margin continued to increase to a record high of 18.8%, reflecting the strength of our operating model. And lastly, we have continued to make strides forward in our infrastructure overhaul, having successfully migrated our largest site onto our new infrastructure by year-end. We expect to have the two remaining smaller sites completed, bringing the overall project to an end. This new infrastructure is already enabling much more speed and agility and creates an excellent foundation for future growth. Moving to the next slide, slide five, and focusing on the US performance, our like-for-like sales volumes in the US grew by 40% year on year despite the high comparators from last year. In addition, we recognize the strong development in our new consumers in recent quarters. And lastly, in mid-September, we resumed sales of Zyn in the US. This comes on the back of a mutually beneficial agreement, where the brand will also avail itself of our media and insight services. We recognize that there are many loyal Zyn consumers who were forced to buy from other retailers over the past year, and we are now placing an emphasis on reactivating those consumers. Moving to slide six and the US outlook, the FDA is piloting a new approval process, which aims to process products from four of the leading manufacturers before the end of 2025. While this process doesn't guarantee that each product will be approved, it may signal an acceleration in the range of new products entering the market on the back of the ever-improving landscape in the US. Haypp Group is preparing to accelerate new consumer inflow. Haypp Group initiated a deep market analysis during Q3 with a third-party specialist firm. The goal of the analysis is to identify the evolving needs of different offline consumer segments and how to overcome impediments to them shopping online. This work is expected to be completed by the end of this year. In conjunction with this, Haypp Group has commissioned a marketing agency with specific expertise related to our business, with the intent of engaging key consumer segments to accelerate our new consumer inflow. The lessons from our pilots this year, such as same-day delivery, out-of-store advertising, referral programs, and loyalty programs, are feeding into this marketing plan, and we expect it to be operational in early 2026. Moving to slide seven with an update on our regulatory and legal. Starting with the US, in addition to the point on the prior slide regarding the FDA's pilot program to process a range of SKUs before year end. We expect the most notable changes to occur regarding state-level taxes on nicotine pouches during 2026. As more information becomes available, we will continue to update you. It should also be noted that there is a referendum underway in Denver, Colorado on tobacco products. Flavored nicotine pouches are included in this category. Regarding the EU, in addition to the PTE, which we spoke of last quarter, the EU Commission is preparing a submission for the FCTC. These discussions are likely to generate a variety of headlines that, over time, will likely moderate, and we remain optimistic about the regulatory outlook in Europe, where the more aggressive positions are opposed by member states led by Sweden. In the UK, the Tobacco and Vape bill is currently being discussed in Parliament. We hope the bill will implement nicotine pouch product standards in line with Haypp Group policies to address various litigation types. Legal proceedings in Stockholm are expected to take between 3 to 9 months, and regarding San Francisco, a settlement was reached in October, removing the US litigation risk. With that, I will now hand over to Peter for an update on our financial performance. Thank you, Gavin. Good afternoon, everyone. Before going into the details, I just would like to express my gratitude.

Peter Delhi
05:18 - 15:54

To highlight, we concluded a solid quarter. As Gavin already elaborated on, we successfully relaunched Zyn, the market-leading brand on all US storefronts, and we maintained our strong gross margin levels. This allows us to initiate the necessary investment, primarily towards the US market, to lay the foundation for the next growth chapter. Despite the increased level of investments, our adjusted EBIT remained flat versus the same period last year at 3.5%. On slide eight, let me begin with our serious development. Like-for-like comparison became even more complex because we have to adjust for 2025 Q3 reported numbers as well. To make the numbers comparable, in Q3 of 2020 we had Zyn in the US for the full quarter, while in Q3 of 2025 we saw this brand only for 19 days. Our reported sales grew by 1%, excluding the FX impact. Excluding the FX impact, the increase was 3%. Like-for-like sales growth was 15%. There is no change in the product composition of growth drivers. The 15% like-for-like growth is mainly driven by nicotine pouches, with Snus remaining in decline, primarily in Sweden, impacting our performance negatively by 5%, partly offset by the emerging segment's contribution to growth of 2%. The Snus decline accelerated during the quarter. However, on a going forward basis, we expect it to moderate. Moving to the next slide. Slide nine and going into more details about our like-for-like sales development, you can find the key drivers. The net impact included in the reported sales, driven by the discontinuation of US Zyn tobacco and the closure of some states in the US, was 92 million. As said before, foreign exchange (FX) also created a headwind. The impact of the foreign exchange movements remained in line with the first half of the year. The depreciation of the Norwegian krone and the US dollar against the Swedish krona has negatively affected reported sales. Zooming into the operational performance, all reporting segments contributed to the like-for-like basis growth segment. The US particularly remained the biggest driver, accounting for 50.54% of the operational growth. The core segment represented 29%, while the emerging segment was 17%. Moving to slide ten and going down a few lines in the P&L, you can find the long-term quarterly development of Haypp Group gross margin, both in absolute terms and as a percentage of net sales. Q3's margin levels remained in line with the first half of 2025. Compared to last year, not only in terms of the margin rate but also the key drivers of the increase remained the same year after year. The sustained margin performance is the foundation for the execution of our growth strategy in the US. This allows us to make the investment required to set the foundation of the next growth chapter. It's important to highlight that going forward, the return of Zyn is not expected to negatively impact our margin levels. Sustaining a strong media and insights business will remain important, and the continued development of those products is pivotal. I would like to reaffirm the foundational principles of our business model. We allocate the value created by our company across our consumers, business partners, and shareholders. Our ongoing priority is to enhance the value we provide to consumers, which in turn requires us to strengthen the value we generate for our business partners by continuously improving our media and insights offerings. We are able to deliver greater value and convenience to our consumers, while also driving healthier profit margins over the medium term. On slide 11, you can find an overview of our overhead-based development, which increased to 126 million for the third quarter. The increase is mainly driven by the development of our US team. We further strengthened our media and insights teams and also invested in activation to increase the online channel and boost brand awareness. On slide 12, you can find key figures around our profitability. Adjusted EBIT for the third quarter grew by 0.9%, reaching 33.4 million. The adjusted EBIT margin remained flat at 3.5%. We benefited from the increase in gross margin. However, we invested this increase in overheads and marginally in paid marketing. The increase in depreciation, similar to previous quarters, is driven by the US automation, which we installed in mid-December last year. We maintained our investment in the emerging segment this quarter. The investment amount amounted to 13.1 million SEK and reduced the overall adjusted EBIT of the group by 1.6 percentage points. Adjusted EBIT for the core and growth business was 5.1%, 0.7% higher than the same period last year. Moving into page 13 and core markets, this segment delivered an overall 5% constant currency net sales growth. The quarter started slowly with some acceleration during the second half. Behind the sales growth, two completely different dynamics remained. The Nicotine Pouches segment, which accounted for 57% of the volume for our core markets, maintained its growth and consistently gained share. The Snus segment's volume remained in decline, and this decline accelerated in Q3 compared to the first half of the year. The decline was driven by the reduction of the underlying consumer demand. The opposite dynamics in Nicotine Pouches and Snus mean that nicotine pouches are gaining share, which over time helps the overall growth rates of the segment. The changes in the purchasing customer numbers are also showing the different dynamics. While we are building our nicotine pouch consumer base, the decline in the Swedish snus consumers offsets this. Adjusted EBITDA remained strong for this segment. The 10% Q3 result is 1.3 percentage points above last year. The driver behind the increase is the Media and Insights revenue growth. On the next slide, slide 14, you can find our growth markets performance. Net sales excluding currency impact on a like-for-like basis are up by 39%. While all markets increased their sales, we are very pleased with the high double-digit growth rates in the US and the nicotine pouch volume development in the UK. Adjusted EBITDA moved into negative territory, driven by increased investment levels, mainly in the US. In absolute terms, it amounted to -1.4 million. Secondly, the adjusted EBITDA rate is -0.6%, while profitability is down compared to the same period last year. It is important to note that the gross margin remains stable for the segment. The overhead increase, mainly driven by the US, negatively impacted the business unit. On slide 15, in our emerging segment, the sequential sales growth continued, and we are particularly pleased with the Swedish and German market performance. Unfortunately, operating in the UK vape market remained challenging due to the absence of regulatory enforcement across the entire spectrum of market participants. Haypp Group was and always will be committed to complying with regulation. However, this can create a significant competitive disadvantage in cases where other retailers are not complying in markets and segments where we are market leaders. We can compensate with our weight, but in the UK market, as a challenger, the uneven playing field prohibits us from achieving our ambitions. As you can see on the bottom chart, while Sweden and Germany have maintained their growing trend, this was not the case in the UK. Despite the heavy investments we made both into our consumer offering and our internal capabilities. This is the reason why we decided that throughout Q4 2025, we are going to discontinue or waive Heat-not-Burn sales in the UK market. On page 16, I would like to highlight 3 or 4 selected KPIs. The full list of KPIs is available in the appendix of this presentation. Starting with inventory, the increase compared to Q2 is driven by Zyn in the US with a slight reduction in other inventories in other locations. The inventory increase didn't fully translate into an increase in our working capital, driven by improvements in other components. Net debt to adjusted EBITDA ratio remained at 0.4 times. With this, I would like to hand back to Gavin.

Gavin O'Dowd
15:55 - 17:58

Thank you, Peter. Moving on to our outlook slide. Slide 18. In our view, the long-term future for risk-reduced nicotine products, the online channel, and Haypp Group with its many strengths remains very encouraging. Conditions within the US continue to evolve in a positive direction for Haypp. Haypp Group's operating model continues to generate increasing value for consumers and suppliers, while also providing margin expansion opportunities over the medium term. The expected increase in regulatory requirements is beginning to manifest, which further differentiates us given our sustained focus on investment and long-term compliance. And finally, on slide 19, I would like to touch upon our medium-term guidance from the Capital Markets Day in April, which runs out to 2028. We envision revenue growth rates of 18 to 25% over the period, with the US market being a material contributor. This reflects the lower expected growth rates for 2025 due to the comparatively narrower consumer base in the US. We also guide towards 5.5% EBIT at the end of the period, plus or minus 150 basis points. While we have been materially increasing our Ebit over the past two years, we intend to reinvest into the US to accelerate our market share growth over this period. I would kindly direct your attention to our CMD material, which is available on our website. This provides more detail behind these targets. And lastly, the company does not intend to issue a dividend over this period, instead reinvesting surplus cash flows into the company's further expansion. Before I open up for questions, I would like to take the opportunity to thank our team for their dedicated and hard work in delivering these strong results. With that, I will hand over to the operator for questions.

Operator
18:00 - 18:19

If you wish to ask a question, please dial the Pound Key on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial the Pound Key on your telephone keypad. The next question comes from Roderik Van Zeeland from Nightwatch Investment Management. Please go ahead.

Roderik Van Zeeland
18:23 - 19:00

Hello everyone. Thanks for organizing the second call to allow your US-based investors to ask questions. Much appreciated. I have a couple of questions. There was this comment from Peter that the return of Zyn is not expected to negatively impact your margin levels. I think historically, Zyn margins were a bit lower. I'm just wondering whether this is a result of a better procurement contract that you have in place with Philip Morris, or whether you expect them to spend more on media and insights as they have in the past, which would also improve margins.

Gavin O'Dowd
19:02 - 19:42

Good morning, Roderik. I hope all is going well. Yes. Of course, there is a limitation on what I can disclose regarding our relationship with a third party, but I can say that we feel the terms we are now working with that brand owner on are mutually beneficial to both sides. So, we consider it to be quite healthy in terms of where the terms stand for both parties, and we hope that it will be a constructive arrangement over the medium term concerning the overall gross margin within the US.

Roderik Van Zeeland
19:44 - 20:27

All right. Understood. I just finished listening to the call you did earlier today, and you provided quite a bit of insight into the steep ramp-up you're seeing now that Zyn is on offer again on your website. I'm just trying to understand a little bit better. I think the key data point was that you're seeing 60% volume growth year-on-year in the US. To start with, is that the overall growth? Because I guess there's a bit of cannibalization. Consumers move from Zyn to VLO or another product, and possibly now back to Zyn. If we're putting it all together, then you're seeing 60% volume growth. Is that the way to look at it?

Gavin O'Dowd
20:27 - 21:37

Yeah. Absolutely. So there was a question on that one earlier today. And the question was what sort of growth performance were we seeing during October? I had said that our volume growth for October in the US was coming in at around 60% year on year. And it's made up of probably three factors in this case. One factor is the continued growth of non-Zyn sales. However, mitigating that is a significant number of non-Zyn consumers moving back to Zyn. Returning to Zyn, now that we have the products available as well. And in addition to that, there is the factor of New Zealand consumers coming to our platform, both new consumers who haven't been with us before, and those we have reactivated who were with us before. So, I think what you can probably conclude here is that perhaps 40% of that 60% or a bit more is directed towards Zyn itself. But they have changed what they're putting in their baskets from being a non-Zyn product to a Zyn product. When I say 40%, I mean 40 percentage points.

Roderik Van Zeeland
21:40 - 21:59

Percentage points. And then I just finished listening to the call you did earlier today, and you gave quite a bit of insight there in the steep ramp up that you're seeing now that Zyn is on offer again on your website. Yes. If you're seeing 60% volume growth, would the revenue growth be in the same order of magnitude? I guess moving targets, there are media insights showing somewhat in line with that number or at a lower rate.

Gavin O'Dowd
21:59 - 22:40

In general, what we can see is that media insights across all markets in the US, especially in the growth markets, tend to be growing slightly faster than product sales. And that's something that we've experienced for a number of years. And then when it comes to the actual product sales themselves, there seems to be at this point in time, a very close relationship between volume growth and revenue growth, as pricing is reasonably comparable to what we were experiencing last quarter. But that can change a little bit from month to month, especially as you're getting through months where there are often quite high promotions, such as November with Black Friday and events like that.

Roderik Van Zeeland
22:43 - 23:08

Right. How should I look at the contribution margin if I start modeling all of this and probably modeling an 18% gross profit margin on the incremental sales?

Gavin O'Dowd
23:08 - 23:53

I think we will continue to invest in the organization within the US, and therefore, there will be an element of that. I'm also conscious of not giving too much guidance on this one. We generally don't give much guidance looking forward anyway, particularly not on the US specifically at this stage, since the environment is moving quite fast. But it hasn't been particularly long since we got settled in, and we're also starting to focus on how we can further accelerate the inflow of new consumers. So I think there are actually quite a few moving parts on this one, Roderick, when it comes to modeling it out into a quarterly number. And I think it's something that we probably wouldn't mind another quarter or two for things to settle down, and then it will become a little bit clearer on what the trajectory of it is from there.

Roderik Van Zeeland
23:56 - 24:19

I totally get that. I think your third quarter was a quarter where investments in the US had moved up without seeing any corresponding revenue, and it just seems like we're going to see a lot of that revenue in Q4. Yeah. Coming in at a decent margin. There are a lot of fixed costs. I think also in your warehouse in Texas. So, there's a lot to be excited about.

Gavin O'Dowd
24:20 - 24:44

Exactly. And the way I view this one, Roderick, is that most of the uptake you will see in Q4 is probably more coming from having the full portfolio back in again. And much of the investment we've been putting in the form of overheads, I don't expect to necessarily have a material impact in Q4, but more starting to have a notable impact as we get through 2026 when it comes to overall growth rates.

Roderik Van Zeeland
24:47 - 24:57

All right. I could keep going with questions, but I don't know how many other people there are on the call from last quarter. Not that many, but I'll hand it over to the next person.

Gavin O'Dowd
24:57 - 24:59

Thank you very much. Thank you.

Operator
25:03 - 25:08

The next question comes from Eben Hudson from Hudson, 215 Capital. Please go ahead.

Eben Hudson
25:10 - 25:42

Hello, Gavin. Hello, Peter. I have 3 or 4 questions. First, Zyn pricing on Nicokick and Northerner is very aggressive at the moment, but there are also significant promotions for Zyn in brick and mortar locations in Q3. Your price advantage then might have been smaller than usual last quarter. Do you foresee continued nicotine pouch price competition among industry players, and how do you foresee your advantage developing over the next few quarters? Thank you.

Gavin O'Dowd
25:42 - 27:19

Good morning, Evan. And yes, it's been a dynamic environment, particularly, I would say, from late August through September. To an extent, through October as well. But it seems to be starting to take a slightly different shape out there. And I think if I take a look at the average pricing of what's going on in the market for some products out there, particularly the market leader, there has been aggressive promotion. But that promotion, if you take a look at the weighted numbers coming through on it, I believe is also reflecting a lot of. Buy one, get one free promotions which are going through there, whereby the original product doesn't necessarily need to be in the basket in order to get a free can as it goes through. So it is very difficult actually to get a full read on what's happening in the market, because it's occurring in certain locations and specific retailers as it runs through. However, we believe that $2.79, which is the cost for the most common unit size in a basket of ten cans, is quite a compelling price for the consumer. I think what's occurring at the moment is that there are numerous moving parts from the consumer's perspective, with regard to different promotions occurring in various chains. And I think we need to see how this settles down as we move further into Q4 and observe where this manifests. But we are pretty happy with the offer that we have on the table at this point in time, and we can see that it is resonating with consumers who come to the site.

Eben Hudson
27:23 - 27:48

Thank you. Secondly, you stated in your Q3 report that in the United States, state and local regulations continue to develop with a primary focus on nicotine pouch taxation. Now, states like Illinois, Indiana, and Tennessee have raised taxes on nicotine pouches in 2025. What are the early indications on revenue and volumes in US states that have raised nicotine taxes?

Gavin O'Dowd
27:48 - 29:08

Thank you. Do you foresee continued nicotine pouch price competition among industry players, and how do you foresee your advantage developing over the next few quarters? So, we've been analyzing the data as various state taxes have been implemented. In general, most of the state taxes are structured as a percentage of wholesale pricing, which effectively means they are a fixed price per unit added to each product, irrespective of the channel through which they're being sold. And the scenario that it creates effectively raises the watermark for everybody involved within the state. So whatever the price gap was prior to the tax, it remains the same price gap after the tax. And in that environment, we generally see very minimal impact when it comes to either the existing consumers or the inflow of new consumers. There is a little bit of noise, often around the edges, whereby on one hand, some of our existing consumers may find this increase somewhat discomforting, but they generally get past that quite quickly when they see it's also happened offline. On the counter side, you often see a bit of an uptick in new customers coming from those locations, where a price shock within the market is often a strong encouragement for people to shop online initially. But in general, if you look through that noisy phase at the beginning, we generally see that those states are progressing comparably to where they were beforehand.

Eben Hudson
29:11 - 29:37

Thank you. Kevin. Peter. The rate of growth of your capitalized development costs moderated in 2023, which was high with a 30% year-over-year growth in 2024. It was in the high 20s. And now in Q3 2025, the capitalized costs grew by 21% year over year. You've just finished an SAP project. Should we expect further moderation in these capitalized costs? Thank you.

Peter Delhi
29:38 - 30:18

Absolutely. There are a few components. What we have to consider, right? It's not only the ERP implementation we are working on, but we also started the ERP implementation combined with the middle layer. And this year, as Gavin alluded to on the operational highlights, we are about to finish the front-end overhaul for the European markets. As soon as that finishes, obviously we will have a state-of-the-art infrastructure which will require significantly less development to be made. So that will obviously drive the capitalized development costs down.

Eben Hudson
30:22 - 30:30

Thank you. Thank you again for holding the call at this time. I'll let others ask questions. Thank you.

Gavin O'Dowd
30:30 - 30:31

Thank you, Evan.

Operator
30:35 - 30:56

As a reminder, if you wish to ask a question, please press the pound key on your telephone keypad. There are no more questions at this time. So I hand the conference back to the speakers for any written questions or closing comments.

Gavin O'Dowd
30:59 - 31:05

Thank you all very much for your time today. Greatly appreciate your attention. Look forward to speaking soon. Thank you.

Peter Delhi
31:06 - 31:07

Thank you, everyone.

Continue to the webcast
Pierce Group, Audiocast, Q3'26
Language: English11/13/2026, 8:00 AM
Göran Dahlin Good morning, everyone, and welcome to Pierce Group's presentation of our Q3 2026 interim results. Next slide, please. I am Göran Dahlin, CEO of Pierce Group, and I am with Fredrik Kjellg…
Surgical Science Sweden, Audiocast, Q3'26
Language: English11/12/2026, 10:00 AM
Tom Englund Hi everyone, and welcome to this earnings call for Surgical Science for the third quarter of 2026. My name is Tom Englund. I am the CEO. And with me today is our CFO, Anna Ahlberg. I wil…
ExpreS2ion Biotech – Presentation of Q3 2026 Interim Report
Language: English11/12/2026, 9:00 AM
ExpreS2ion is expected to release its Q3 2026 interim report on 12 November 2026. Later the same day at 10.00, ExpreS2ion’s CEO Bent U. Frandsen and CFO Keith Alexander will present the results and answer questions in a live online event.
Meko Services AB, Q3'26
Language: English11/12/2026, 8:00 AM
Pat Thank you. Good morning, and welcome to MEKO's presentation of the third quarter of 2026. I am here with our CFO, Christy Johansson, and I will begin with an overview of the quarter and some of th…
WeSports Group, Audiocast, Q3'26
Language: English11/12/2026, 8:00 AM
Unknown 1 It. Ted Sporre Welcome to our Q3 release presentation. As you know, we have already shared preliminary figures for sales and EBITDA for this quarter, but today we complete the picture. We wi…
Nordrest Holding, Audiocast, Q3'26
Language: Swedish11/12/2026, 8:00 AM
Thomas Dahlstedt Hej och välkomna! Vi ska idag presentera Nordrests senaste kvartal och tillika resultatet för perioden. Jag som pratar nu heter Thomas Dahlstedt och är grundare och tillika VD för bol…
Karnov Group, Audiocast, Q3'26
Language: English11/12/2026, 8:00 AM
Pontus Bodelsson Welcome, everyone, to Karnov Group's earnings conference, where we will present the outcome of the third quarter of 2026. Please go to slide two. I am Pontus Bodelsson, President and…
Fasadgruppen Group, Audiocast, Q3'26
Language: English11/12/2026, 7:15 AM
Magnus Blomberg Perfect. Good morning and welcome to the Fasadgruppen presentation of our results for the third quarter 2026. My name is Magnus Blomberg. You have met me before. I am the CFO of Fasadg…
Munters AB, CMD
Language: English11/11/2026, 1:00 PM
Lena Dauvergne Good. Good afternoon everyone, and a warm welcome to Stockholm, to ESSEX and to Montage Capital Markets Day 2026. Montage Capital Markets Day 2026. It is really good to see so many of y…
Cinclus Pharma, Audiocast, Q3'26
Language: English11/11/2026, 1:00 PM
Christer Ahlberg Thank you. Hello and welcome to the Cinclus Pharma third quarter 2026 earnings call. I am Christer Ahlberg, CEO of Cinclus Pharma, and with me today is our CFO, Magnus Christensen. We…
Proact IT, CMD
Language: English11/11/2026, 12:30 PM
Unknown 1 The world of data is constantly changing. Breaches are rising, and attacks are getting more advanced. Regulation drives the need for data sovereignty. Data has to be available. Critical busi…
Ferronordic AB, Audiocast, Q3'26
Language: English11/11/2026, 9:00 AM
Henrik Good morning, everyone, and welcome to our presentation of the third quarter of 2026. During the quarter, we saw higher earnings, and growing aftermarket revenue was up 15% to 1.2 billion Swedi…
BICO, Audiocast, Q3'26
Language: English11/11/2026, 9:00 AM
Anders Fogelberg Good morning, everyone, and welcome to BICO's earnings call for the third quarter of 2026. I am Anders Fogelberg, President and CEO of BICO. And joining me today is our Group CFO, Ewa…
Catena Media, Audiocast, Q3'26
Language: English11/10/2026, 5:00 PM
Manuel Stan Good afternoon. Good evening, everyone. Welcome to the Catena Media Q3 Interim Report. I am Manuel Stan and today I'm joined by our Chief Financial Officer, Michael Gerrow. Today we will b…
Ellos Group, Q3'26
Language: English11/10/2026, 8:00 AM
Hans Ohlsson Live. Good morning, everyone, and welcome to the second presentation for Ellos Group as a listed company. We have 45 minutes today for the presentation. And there is a hard stop. After th…
Scandic Hotels Group, Audiocast, Q3'26
Language: English11/10/2026, 8:00 AM
Jens Mathisen Thank you so much, and good morning, everyone, and thank you for joining us for the Q3 presentation. I am Jens Mathisen, CEO of Scandic. And joining me is our CFO, Pierre Carstensen. We…
Svevik Industri, Q3'26
Language: Swedish11/6/2026, 9:00 AM
Johan Hårdén Tack så mycket! Hello and welcome to this hearing regarding the Q3 2026 interim report. We have an agenda where we intend to introduce ourselves to all the new shareholders as well. Kort…
Attendo, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
Martin Tivéus Good morning, everyone, and thank you for joining us. Today, we will present our results for the third quarter of 2026. I am pleased to announce that this is the strongest quarter for At…
Cavotec, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
David Pagels Good morning and welcome to Cavotec's Q3 2026 presentation. I am David Pagels, the CEO of Cavotec. And together with me today, I have our new CFO, Christoffer Robertsson. I would like to…
Fractal Gaming Group, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
Jonas Good morning, everyone, and welcome to Fractal's Q3 2026 presentation. Today, we'll take you through our results, the progress that we've made, and our priorities ahead after a difficult first h…